V. Blazevic et al., T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy, AIDS RES H, 16(17), 2000, pp. 1887-1893
The effect of highly active antiretroviral therapy (HAART) on T cell respon
ses in 30 HIV-infected patients was studied. Lymphocyte proliferation in re
sponse to influenza A virus, HIV-1 p24, gp160, allogeneic leukocytes, and m
itogen, as well as influenza-specific cytotoxic T lymphocyte (CTL) response
s, were measured. AIDS patients had decreased T cell-proliferative response
s to influenza and alloantigen compared with asymptomatic patients. Absence
of positive proliferative responses of HIV-infected patients to HIV-1 anti
gens was not associated with increased interleukin 10 production. Correlati
on was observed between influenza-specific CTL response and T cell prolifer
ation, as well as CD4(+) T lymphocyte counts, indicating the importance of
CD4(+) helper T cells for generating antiviral CTL responses. Finally, thes
e results show that HAART-treated asymptomatic patients, but not AIDS patie
nts, have T cell responses comparable to those of control individuals. It r
emains to be determined whether immune-based therapy will contribute any ad
ditional benefit to patients who received HAART.